Drug Shortage Report for APO-QUETIAPINE XR

Last updated on 2020-06-29 History
Report ID 76735
Drug Identification Number 02457237
Brand name APO-QUETIAPINE XR
Common or Proper name QUETIAPINE
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) QUETIAPINE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 60 BTL
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-02-20
Estimated end date 2020-08-14
Actual end date
Shortage status Actual shortage
Updated date 2020-06-29
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-06-29 French Compare
v11 2020-06-29 English Compare
v10 2020-04-24 French Compare
v9 2020-04-24 English Compare
v8 2019-05-27 French Compare
v7 2019-05-27 English Compare
v6 2019-05-03 French Compare
v5 2019-05-03 English Compare
v4 2019-04-11 French Compare
v3 2019-04-11 English Compare
v2 2019-02-24 French Compare
v1 2019-02-24 English Compare